Statin Type and Cancer Outcomes in Patients with Diabetes Type 2 and Solid Tumors.

J Res Pharm Pract · 2021 · PMC8259595 · PMID 34295853

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Pravastatin was associated with improved OS (HR: 0.674, 95% CI: 0.471–0.964) but showed a nonsignificant trend toward improvement in DFS (HR: 0.742, 95% CI: 0.532–1.037) [ Table 2 ].

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.